Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$27.7M
four quarters, 2024-01-01 to 2024-12-31
Revenue, TTM VISL
FY Dec 2024
$27.7M
FY Dec 2023
$27.5M
FY Dec 2022
$28.4M
FY Dec 2021
$33.9M
FY Dec 2020
$22.9M
Dec 2024
$3.4M
Sep 2024
$7.1M
Jun 2024
$8.7M
Mar 2024
$8.6M
Dec 2023
$8.1M
Sep 2023
$7.2M
Jun 2023
$5.0M
Mar 2023
$7.2M
At each fiscal year end
Single quarter
Net margin, TTM
-73.9%
net income over revenue, 2024-01-01 to 2024-12-31
Net margin, TTM VISL
FY Dec 2024
-73.9%
FY Dec 2023
-33.2%
FY Dec 2022
-47.6%
FY Dec 2021
-48.4%
FY Dec 2020
-76.8%
Dec 2024
-424.4%
Sep 2024
-42.6%
Jun 2024
-26.1%
Mar 2024
-11.0%
Dec 2023
-29.4%
Sep 2023
-27.4%
Jun 2023
-60.0%
Mar 2023
-24.4%
At each fiscal year end
Single quarter
Free cash flow, TTM
-$7.4M
operating cash flow minus capex, 2024-01-01 to 2024-12-31
Free cash flow, TTM VISL
FY Dec 2024
-$7.4M
FY Dec 2023
-$10.4M
FY Dec 2022
-$9.9M
FY Dec 2021
-$9.8M
FY Dec 2020
-$14.6M
Dec 2024
-$2.8M
Sep 2024
-$2.5M
Jun 2024
-$1.8M
Mar 2024
-$232.0K
Dec 2023
-$4.0M
Sep 2023
-$2.9M
Jun 2023
-$2.8M
Mar 2023
-$779.0K
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity VISL
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
FY Dec 2020
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt VISL
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
FY Dec 2020
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-75.7%
TTM net income over average of 2023-12-31 and 2024-12-31
Return on equity VISL
FY Dec 2024
-75.7%
FY Dec 2023
-22.6%
FY Dec 2022
-27.0%
FY Dec 2021
-49.2%
FY Dec 2020
-182.8%
Dec 2024
-75.7%
Sep 2024
-24.4%
Jun 2024
-20.2%
Mar 2024
-20.9%
Dec 2023
-22.6%
Sep 2023
-28.3%
Jun 2023
-28.4%
Mar 2023
-25.7%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-57.6%
TTM net income over average of 2023-12-31 and 2024-12-31
Return on assets VISL
FY Dec 2024
-57.6%
FY Dec 2023
-18.9%
FY Dec 2022
-22.6%
FY Dec 2021
-36.9%
FY Dec 2020
-79.4%
Dec 2024
-57.6%
Sep 2024
-19.5%
Jun 2024
-16.0%
Mar 2024
-17.2%
Dec 2023
-18.9%
Sep 2023
-23.3%
Jun 2023
-23.7%
Mar 2023
-21.7%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
tax provision or pre-tax income not filed for the four quarters
Return on invested capital VISL
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
FY Dec 2020
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
-76.6%
operating income (EBIT proxy) over average of 2023-12-31 and 2024-12-31 minus current liabilities
Return on capital employed VISL
FY Dec 2024
-76.6%
FY Dec 2023
-25.3%
FY Dec 2022
-26.9%
FY Dec 2021
-50.0%
FY Dec 2020
-161.2%
Dec 2024
-76.6%
Sep 2024
-27.4%
Jun 2024
-23.3%
Mar 2024
-23.8%
Dec 2023
-25.3%
Sep 2023
-30.1%
Jun 2023
-29.5%
Mar 2023
-26.1%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing VISL
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
FY Dec 2020
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value VISL
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
FY Dec 2020
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
-73.7%
TTM free cash flow over market value at close 2026-10-26
FCF yield VISL
FY Dec 2024
-78.0%
FY Dec 2023
-112.8%
FY Dec 2022
-1.9%
FY Dec 2021
-0.9%
FY Dec 2020
-2.7%
Dec 2024
-78.0%
Sep 2024
-55.5%
Jun 2024
-83.3%
Mar 2024
-117.9%
Dec 2023
-112.8%
Sep 2023
-49.0%
Jun 2023
-36.8%
Mar 2023
-1.7%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing VISL
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
FY Dec 2020
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
Mar 2024
n/a
Dec 2023
n/a
Sep 2023
n/a
Jun 2023
n/a
Mar 2023
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
VISL ranks highest on risk and compliance (95th percentile) and growth (24th), and lowest on profitability (13th), among Tech Hardware peers.
Profitability
13
Inputs
Return on equity-75.7% · 13 pct, sector of 77
Return on assets-57.6% · 18 pct, sector of 92
Return on invested capitaltax provision or pre-tax income not filed for the four quarters
Return on capital employed-76.6% · 8 pct, sector of 72
Growth
24
Inputs
Revenue growth, YoY+0.9% · 24 pct, sector of 102
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Risk and compliance
95
Inputs
Short interest, % of float+0.1% · 95 pct, sector of 105
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
4 not measured: Financial health, Insider conviction, Institutional and government, US patents
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
3 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.